To determine the effect transient knockdown of KRAS or c-RAF has on PANC1 and Panc08.13 cell viability, the DepMap genome-wide RNAi viability screening database (n = 666 human cancer cell lines) was utilised (Fig. 6A, Fig. S6, Supplementary Data Set 3). The gene discussed is KRAS; the disease is cancer.